Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover 
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales 
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations 
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue 
Telegram Restored on Apple App Store After Temporary Removal 
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal 
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets 
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race 
Jetstar to Charge for Overhead Cabin Bags From February 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring 
Apple Restores Telegram to App Store After Content Policy Violation 
DHL Q2 Profit Jumps 24% as Express Business Drives Growth 
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners 
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth 
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip 
-- Conference Call to Follow at 4:30 p.m. EDT --
HORSHAM, Pa., March 27, 2018 -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, will release fiscal 2017 financial results on Thursday, March 29, after the market close. STRATA Skin Sciences’ President and Chief Executive Officer, Frank J. McCaney, will host a conference call at 4:30 pm Eastern Time to review the Company’s progress.
Conference Call Details:
Date: Thursday, March 29
Time: 4:30 pm Eastern Time
Toll Free: 888-394-8218
International: 323-794-2149
Passcode: 6380302
Webcast: www.strataskinsciences.com
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused on the therapeutic and aesthetic dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN® MicroSystem, marketed specifically for the intended use of micropigmentation; and NORDLYS, a multi-technology aesthetic laser device.
Investor Contacts:
Frank McCaney, Chief Executive Officer
STRATA Skin Sciences, Inc.
215-619-3200
[email protected]
Bob Yedid, Managing Director
LifeSci Advisors, LLC
646-597-6989
[email protected]
